Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

NCT06625190 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma
Rhabdomyosarcoma
Synovial Sarcoma
Peripheral Nerve Sheath Tumors
Clear Cell Sarcoma
Alveolar Soft Part Sarcoma
Desmoplastic Small Round Cell Tumor
Chordoma
Rhabdoid Tumor
Epithelioid Sarcoma
Myoepithelial Tumor
Osteosarcoma
Ewing Sarcoma

Interventions

DEVICE: Miltenyi CliniMACS Prodigy ® system
DRUG: Zoledronic acid

Sponsor

University of Florida